Mutant proteins and methods for selecting them

Details for Australian Patent Application No. 2012200841 (hide)

Owner Heptares Therapeutics Limited

Inventors Magnani, Francesca; Tate, Christopher Gordon; Weir, Malcolm Peter; Henderson, Richard; Warne, Anthony Johannes; Serrano-Vega, Maria Josefa; Shibata, Yoko

Agent Freehills

Pub. Number AU-A-2012200841

Parent 2008228085

Filing date 14 February 2012

Wipo publication date 8 March 2012

International Classifications

C12N 15/10 (2006.01) Mutation or genetic engineering - Processes for the isolation, preparation or purification of DNA or RNA

C07K 14/72 (2006.01) Peptides having more than 20 amino acids

G01N 33/566 (2006.01) Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

Event Publications

1 March 2012 Complete Application Filed

8 March 2012 Application Open to Public Inspection

  Published as AU-A-2012200841

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012200842-Gaming device having dynamic paylines

2012200840-Solid oxide fuel cell device comprising an elongated substrate with a hot and a cold portion